Literature DB >> 8823375

DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.

S Moriwaki1, M Stefanini, A R Lehmann, J H Hoeijmakers, J H Robbins, I Rapin, E Botta, B Tanganelli, W Vermeulen, B C Broughton, K H Kraemer.   

Abstract

Xeroderma pigmentosum (XP)/Cockayne syndrome (CS) complex is a combination of clinical features of two rare genetic disorders in one individual. A sun-sensitive boy (XP20BE) who had severe symptoms of CS, with dwarfism, microcephaly, retinal degeneration, and mental impairment, had XP-type pigmentation and died at 6 y with marked cachexia (weight 14.5 lb) without skin cancers. We evaluated his cultured cells for characteristic CS or XP DNA-repair abnormalities. The level of ultraviolet (UV)-induced unscheduled DNA synthesis was less than 5% of normal, characteristic of the excision-repair defect of XP. Cell fusion studies indicated that his cells were in XP complementation group G. His cells were hypersensitive to killing by UV, and their post-UV recovery of RNA synthesis was abnormally low, features of both CS and XP. Post-UV survival of plasmid pSP189 in his cells was markedly reduced, and post-UV plasmid mutation frequency was higher than with normal cells, as in both CS and XP. Sequence analysis of the mutated plasmid marker gene showed normal frequency of plasmids with multiple base substitutions, as in CS, and an abnormally increased frequency of G:C-->A:T mutations, a feature of XP. Transfection of UV-treated pRSVcat with or without photoreactivation revealed that his cells, like XP cells, could not repair either cyclobutane pyrimidine dimers or non-dimer photoproducts. These results indicate that the DNA-repair features of the XP20BE (XP-G/CS) cells are phenotypically more like XP cells than CS cells, whereas clinically the CS phenotype is more prominent than XP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823375     DOI: 10.1111/1523-1747.ep12584287

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

1.  Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy.

Authors:  J M Graham ; K Anyane-Yeboa; A Raams; E Appeldoorn; W J Kleijer; V H Garritsen; D Busch; T G Edersheim; N G Jaspers
Journal:  Am J Hum Genet       Date:  2001-07-03       Impact factor: 11.025

2.  Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage.

Authors:  Fabrizio Thorel; Angelos Constantinou; Isabelle Dunand-Sauthier; Thierry Nouspikel; Philippe Lalle; Anja Raams; Nicolaas G J Jaspers; Wim Vermeulen; Mahmud K K Shivji; Richard D Wood; Stuart G Clarkson
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

4.  Mechanism of open complex and dual incision formation by human nucleotide excision repair factors.

Authors:  E Evans; J G Moggs; J R Hwang; J M Egly; R D Wood
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

5.  The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts.

Authors:  S Emmert; N Kobayashi; S G Khan; K H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 6.  Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders.

Authors:  Mohsen Hosseini; Khaled Ezzedine; Alain Taieb; Hamid R Rezvani
Journal:  J Invest Dermatol       Date:  2014-10-09       Impact factor: 8.551

7.  The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms.

Authors:  S Emmert; T D Schneider; S G Khan; K H Kraemer
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

Review 8.  Cockayne syndrome and xeroderma pigmentosum.

Authors:  I Rapin; Y Lindenbaum; D W Dickson; K H Kraemer; J H Robbins
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

9.  Identification of the XPG region that causes the onset of Cockayne syndrome by using Xpg mutant mice generated by the cDNA-mediated knock-in method.

Authors:  Naoko Shiomi; Seiji Kito; Masaki Oyama; Tsukasa Matsunaga; Yoshi-Nobu Harada; Masahito Ikawa; Masaru Okabe; Tadahiro Shiomi
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 10.  XPG: its products and biological roles.

Authors:  Orlando D Schärer
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.